Diagnostic and Prognostic Validity of Serum Golgi Protein 73 in Egyptian Patients with Hepatocelluar Carcinoma

P53 and endoglin, two biomarkers for predicting HBV and hepatocellular carcinoma in Egyptian patients

Evaluation of serum Midkine as a Diagnostic Marker for Hepatocellular Carcinoma in Hepatitis C virus Patients with Liver Cirrhosis

Evaluation of osteopontin as a potential biomarker in hepatocellular carcinoma in a sample of Egyptian patients

Assessment of CEA and CA15-3 as Potential Prognostic Markers for Breast Cancer in Egyptian Females.

Serum Pentraxin 3 as a Biomarker of Hepatocellular Carcinoma in Egyptian Liver Cirrhotic Patients

Serum levels of ace, angiotensin II and CA19-9 in Egyptian patients with liver cirrhosis and in hepatocellular carcinoma

Assessment of Serum Aldo-Keto Reductase Family 1 Member B10 for Early Diagnosis of Hepatocellular Carcinoma Patients in Suez Canal University Hospital, Egypt ‎

SERUM LEVEL OF HEPCIDIN IN CIRRHOTIC PATIENTS AS A MARKER FOR HEPATOCELLULAR CARCINOMA

Study of the Serum Level of Annexin A5 as a Marker for Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis Patients